EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

C ‐Reactive Protein–Triglyceride–Glucose Index and Coronary Artery Calcium Progression: A Prospective Cohort Analysis

Qing-Yun Hao, Ze-Hua Li, Jun Weng, Zi-Bin Zhan, Kun-Hao Bai, Jing-Bin Guo, Xiao-Ping Cui, Jing-Wei Gao, Yu-Hong Zeng iD

Clinical Cardiology · 2026-04 · 49 (4)

DOI: 10.1002/clc.70304 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Cardiology, online erschienen am 16.04.2026. Verfasst von Qing-Yun Hao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The affiliated Hospital of Inner Mongolia Medical University, Hohhot, China. Hauptthemen laut MEDLINE: Blood Glucose, C-Reactive Protein, Coronary Artery Disease, Coronary Vessels. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Guangzhou, Guangdong Medical Equipment Association Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The C ‐reactive protein–triglyceride–glucose index (CTI) reflects systemic inflammation and insulin resistance, but its relationship with coronary artery calcium (CAC) progression remains unclear. This study examined the association between CTI and CAC progression in a longitudinal cohort.

Methods

Participants from the Coronary Artery Risk Development in Young Adults (CARDIA) study with CAC measurements at years 15, 20, and 25 were included. CTI was calculated from fasting blood samples at year 15 and categorized into quartiles. CAC was quantified using standardized computed tomography. CAC progression was defined as incident CAC > 0 for those with baseline CAC = 0, an annualized CAC increase ≥ 10 units for those with baseline CAC: 0–100, or an annualized percent increase ≥10% for those with baseline CAC ≥ 100. Cox proportional hazards models estimated hazard ratios (HRs), adjusting for cardiovascular risk factors.

Results

Among 2655 participants (mean age 40.3 ± 3.6 years; 44.7% men), 704 (26.5%) experienced CAC progression over 8.9 ± 2.0 years. After adjustment, individuals in the highest CTI quartile had a 38% higher risk of CAC progression compared with the lowest quartile (HR = 1.380; 95% CI: 1.072–1.775). Subgroup analyses by age, sex, race, body mass index, and baseline CAC status were consistent, and results remained robust after excluding participants with baseline diabetes or lipid‐lowering medication use.

Conclusions

Higher CTI was independently associated with increased CAC progression, supporting its potential utility as a biomarker for identifying individuals at elevated risk of subclinical atherosclerosis. Trial Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00005130.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood GlucoseC-Reactive ProteinCoronary Artery DiseaseCoronary VesselsTriglyceridesVascular CalcificationAdultFemaleHumansMaleBiomarkersCoronary AngiographyDisease ProgressionFollow-Up StudiesIncidenceProspective StudiesRisk AssessmentRisk FactorsTime FactorsUnited States

Stichwörter der Autor:innen

C‐reactive protein‐triglyceride‐glucose indexcardiovascular diseasecoronary artery calciuminflammationinsulin resistancerisk factors

Substanzen

BiomarkersBlood GlucoseC-Reactive ProteinTriglycerides

Autor:innen und Institutionen

  • Department of Cardiology, The affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
  • State Key Laboratory of Oncology in South China, Department of Endoscopy, Sun Yat-sen University Cancer Center, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.
  • Department of Hepatobiliary Surgery II, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Laboratory of Heart Center, Department of Cardiology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Medical Engineering Department, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

ORCID-Profile: Yu-Hong Zeng

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Program of Guangzhou
  • Guangdong Medical Equipment Association Research Fund
  • CARDIA
  • NHLBI NIH HHS
  • National Institutes of Health, of the United States
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Hao, Q. Y., Li, Z. H., Weng, J., Zhan, Z. B., Bai, K. H., Guo, J. B., Cui, X. P., Gao, J. W., & Zeng, Y. H. (2026). C ‐Reactive Protein–Triglyceride–Glucose Index and Coronary Artery Calcium Progression: A Prospective Cohort Analysis. Clinical Cardiology, 49(4). https://doi.org/10.1002/clc.70304

Vancouver

Hao QY, Li ZH, Weng J, Zhan ZB, Bai KH, Guo JB, et al. C ‐Reactive Protein–Triglyceride–Glucose Index and Coronary Artery Calcium Progression: A Prospective Cohort Analysis. Clinical Cardiology. 2026;49(4). doi:10.1002/clc.70304

BibTeX
@article{Hao2026,
  author = {Hao, Qing-Yun and Li, Ze-Hua and Weng, Jun and Zhan, Zi-Bin and Bai, Kun-Hao and Guo, Jing-Bin and Cui, Xiao-Ping and Gao, Jing-Wei and Zeng, Yu-Hong},
  title = {C ‐Reactive Protein–Triglyceride–Glucose Index and Coronary Artery Calcium Progression: A Prospective Cohort Analysis},
  journal = {Clinical Cardiology},
  year = {2026},
  volume = {49},
  number = {4},
  doi = {10.1002/clc.70304}
}
Kostenlos starten →